MENU
+Compare
ACET
Stock ticker: NASDAQ
AS OF
Dec 4, 01:26 PM (EDT)
Price
$0.56
Change
+$0.02 (+3.70%)
Capitalization
82.41M

ACET Adicet Bio Forecast, Technical & Fundamental Analysis

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases... Show more

ACET
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ACET with price predictions
Nov 28, 2025

ACET sees its Stochastic Oscillator ascending out of oversold territory

On November 28, 2025, the Stochastic Oscillator for ACET moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 64 instances where the indicator left the oversold zone. In of the 64 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ACET's RSI Indicator exited the oversold zone, of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ACET just turned positive on November 26, 2025. Looking at past instances where ACET's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ACET advanced for three days, in of 279 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACET declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ACET entered a downward trend on November 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.754) is normal, around the industry mean (27.112). P/E Ratio (0.000) is within average values for comparable stocks, (52.721). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.882). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (324.716).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ACET’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACET’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ACET
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ACET is expected to report earnings to fall 34.55% to -18 cents per share on March 05

Adicet Bio ACET Stock Earnings Reports
Q4'25
Est.
$-0.19
Q3'25
Beat
by $0.01
Q2'25
Missed
by $0.03
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.03
The last earnings report on November 05 showed earnings per share of -28 cents, beating the estimate of -30 cents. With 797.35K shares outstanding, the current market capitalization sits at 82.41M.
A.I.Advisor
published Dividends

ACET paid dividends on October 09, 2018

Adicet Bio ACET Stock Dividends
А quarterly dividend of $0.01 per share was paid with a record date of October 09, 2018, and an ex-dividend date of September 21, 2018. Read more...
A.I. Advisor
published General Information

General Information

a distributor of pharmaceutical intermediate ingrediants and other industrial chemicals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Distributors
Address
131 Dartmouth Street
Phone
+1 650 503-9095
Employees
143
Web
https://www.adicetbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
THSGF1.620.01
+0.75%
THESIS GOLD INC.
ACBD0.98N/A
N/A
Annabidiol Corp.
LNVGF1.25N/A
-0.40%
Lenovo Group Ltd.
VGPBF116.33-1.74
-1.48%
VGP SA
DGTEF0.01-0.01
-44.20%
DIGITAL ASSET TECHNOLOGIES INC.

ACET and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with RGNX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
-8.24%
RGNX - ACET
45%
Loosely correlated
-3.10%
OGI - ACET
41%
Loosely correlated
+0.64%
IPSC - ACET
41%
Loosely correlated
-2.62%
SYRE - ACET
41%
Loosely correlated
-0.91%
DVAX - ACET
39%
Loosely correlated
+1.54%
More

Groups containing ACET

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
-8.24%
pharmaceuticals
theme (143 stocks)
29%
Poorly correlated
+1.48%
medical devices
theme (58 stocks)
24%
Poorly correlated
+0.70%
industrial
theme (22 stocks)
22%
Poorly correlated
+0.76%